Tree of Knowledge International Corp. announced that the company has entered into a Sponsored Research Agreement with Ryerson University to conduct additional research on the Company's innovative ultrasound technology combined with novel nano technology delivery methods to enhance the efficacy of medical Cannabis and Cannabidiol (CBD) derived therapeutics. Pursuant to the Sponsored Research Agreement the company will own any intellectual property that is created or developed in the course of performing the research. A key component of the Company's business plan includes conducting large-scale studies and clinical trials on various cannabinoids using various treatment methods in collaboration with notable universities. The goal is to generate statistically significant data to drive and refine product development in order for the Company to further differentiate its products from its competitors. With extraordinary patient access and broad distribution capability across North America and international markets, Management believes TOK's primary competitive advantage is the benefits it can derive from access to one of the continent's larger patient populations through its strategic relationships with clinics and physicians in the US and Canada.